Learn about the groundbreaking $1 bandage that generates its own electrical field to accelerate healing of chronic wounds.

MediWound , an Israeli developer of products to treat burns and wounds using non-surgical tissue repair, said on Wednesday it was starting a Phase III trial for its treatment for venous leg ulcers.

Skin substitute grafts made from cellular and tissue-based products have helped to revolutionize chronic wound care, but federal regulators are greatly reducing coverage for Medicare beneficiaries.

As home health providers increasingly serve people with more complicated and serious conditions, and the push for ...

Argent BioPharma Ltd. (ASX: RGT) (OTCQB: RGTLF) has made significant progress in its collaboration with SINTEF to enhance antimicrobial therapies for chronic wounds and potential oncologic wound care.

View Full Profile. Learn about our Editorial Policies. “This study is unique in terms of bringing light on the good part of the chronic wound microbiome,” said Irena Pastar, who researches microbiome ...

A key driver is the rising prevalence of chronic wounds. The global wound care devices market is projected to hit $4b by 2032 ...

A new research paper was published by Aging (Aging-US) on December 3, 2024, in Volume 17, Issue 1, titled "Topical ABT-263 treatment reduces aged skin senescence and improves subsequent wound healing.

MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced the initiation of VALUE, a global, pivotal Phase III trial evaluating ...